Drupal.behaviors.print = function(context) {window.print();window.close();}>
Eisai to Dissolve Dx R&D Subsidiary as It Focuses on Personalized Medicine
October 10, 2012
Eisai to Dissolve Dx R&D Subsidiary as It Focuses on Personalized Medicine
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Foundation Medicine to Develop Dx for Agios Cancer Therapeutics
April 4, 2013 / GenomeWeb Daily News
Empire Genomics, Icon Team on Personalized Medicine Services
November 9, 2011 / GenomeWeb Daily News
Iris Restructures Personalized Medicine Division
September 7, 2011 / GenomeWeb Daily News
Ignyta Buys Personalized Medicine Firm Actagene
May 21, 2013 / GenomeWeb Daily News
ICR, Wellcome Trust, Illumina Launch Clinical Genetic Testing Effort
May 20, 2013 / GenomeWeb Daily News